| Management of febrile neutropenia: ESMO clinical practice guidelines J De Naurois, I Novitzky-Basso, MJ Gill, FM Marti, MH Cullen, F Roila Annals of Oncology 21, v252-v256, 2010 | 571 | 2010 |
| Induction of a CD8+ T-cell response to the MAGE cancer testis antigen by combined treatment with azacitidine and sodium valproate in patients with acute myeloid … O Goodyear, A Agathanggelou, I Novitzky-Basso, S Siddique, ... Blood, The Journal of the American Society of Hematology 116 (11), 1908-1918, 2010 | 374 | 2010 |
| The atypical chemokine receptor CCRL1 shapes functional CCL21 gradients in lymph nodes MH Ulvmar, K Werth, A Braun, P Kelay, E Hub, K Eller, L Chan, B Lucas, ... Nature immunology 15 (7), 623-630, 2014 | 287 | 2014 |
| Differential DARC/ACKR1 expression distinguishes venular from non-venular endothelial cells in murine tissues A Thiriot, C Perdomo, G Cheng, I Novitzky-Basso, S McArdle, ... BMC biology 15, 1-19, 2017 | 142 | 2017 |
| Molecular MRD status and outcome after transplantation in NPM1-mutated AML R Dillon, R Hills, S Freeman, N Potter, J Jovanovic, A Ivey, AS Kanda, ... Blood, The Journal of the American Society of Hematology 135 (9), 680-688, 2020 | 139 | 2020 |
| Atypical chemokine receptor 1 on nucleated erythroid cells regulates hematopoiesis J Duchene, I Novitzky-Basso, A Thiriot, M Casanova-Acebes, M Bianchini, ... Nature immunology 18 (7), 753-761, 2017 | 100 | 2017 |
| Duffy antigen receptor for chemokines and its involvement in patterning and control of inflammatory chemokines I Novitzky-Basso, A Rot Frontiers in immunology 3, 266, 2012 | 89 | 2012 |
| Children and adults with refractory acute graft-versus-host disease respond to treatment with the mesenchymal stromal cell preparation “MSC-FFM”—outcome report of 92 patients H Bonig, Z Kuçi, S Kuçi, S Bakhtiar, O Basu, G Bug, M Dennis, J Greil, ... Cells 8 (12), 1577, 2019 | 47 | 2019 |
| Target spectrum of the BCR-ABL tyrosine kinase inhibitors in chronic myeloid leukemia H Lee, IN Basso, DDH Kim International journal of hematology 113 (5), 632-641, 2021 | 45 | 2021 |
| Myocardial infarction following recombinant activated factor VII in a patient with type 2A von Willebrand disease IN Basso, D Keeling Blood coagulation & fibrinolysis 15 (6), 503-504, 2004 | 36 | 2004 |
| Bloodstream infections and outcomes following allogeneic hematopoietic cell transplantation: a single-center study AS Carreira, MQ Salas, M Remberger, IN Basso, AD Law, W Lam, I Pasic, ... Transplantation and Cellular Therapy 28 (1), 50. e1-50. e8, 2022 | 19 | 2022 |
| Optimal duration of imatinib treatment/deep molecular response for treatment‐free remission after imatinib discontinuation from a Canadian tyrosine kinase inhibitor … DDH Kim, I Novitzky‐Basso, TS Kim, EG Atenafu, D Forrest, L Savoie, ... British Journal of Haematology 193 (4), 779-791, 2021 | 17 | 2021 |
| Prognostic impact of the adverse molecular-genetic profile on long-term outcomes following allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia G Daher-Reyes, TH Kim, I Novitzky-Basso, KH Kim, A Smith, T Stockley, ... Bone Marrow Transplantation 56 (8), 1908-1918, 2021 | 14 | 2021 |
| Allogeneic transplant can abrogate the risk of relapse in the patients of first remission acute myeloid leukemia with detectable measurable residual disease by next-generation … JS Ahn, TH Kim, SH Jung, SY Ahn, SY Jung, GY Song, M Kim, DH Yang, ... Bone Marrow Transplantation 56 (5), 1159-1170, 2021 | 13 | 2021 |
| Impact of hematopoietic cell transplant frailty scale on transplant outcome in adults MQ Salas, EG Atenafu, I Pasic, E Al-Shaibani, O Bascom, L Wilson, ... Bone Marrow Transplantation 58 (3), 317-324, 2023 | 9 | 2023 |
| Improving safety and outcomes after allogeneic hematopoietic cell transplantation: a single-center experience MQ Salas, I Pasic, M Remberger, I Novitzky-Basso, AD Law, W Lam, ... Transplantation and Cellular Therapy 28 (5), 265. e1-265. e9, 2022 | 9 | 2022 |
| Anti‐thymocyte globulin and post‐transplant cyclophosphamide predisposes to inferior outcome when using cryopreserved stem cell grafts I Novitzky‐Basso, M Remberger, C Chen, I Pasić, W Lam, A Law, ... European Journal of Haematology 108 (1), 61-72, 2022 | 9 | 2022 |
| Clonal hematopoiesis in the donor does not adversely affect long-term outcomes following allogeneic hematopoietic stem cell transplantation: result from 13-year followup KH Kim, TH Kim, I Novitzky-Basso, H Lee, Y Yoo, JS Ahn, I Pasic, A Law, ... Haematologica, 2023 | 8 | 2023 |
| Final report of TKI discontinuation trial with dasatinib for the second attempt of treatment‐free remission after failing the first attempt with imatinib: Treatment‐free … MA Perusini, I Novitzky‐Basso, EG Atenafu, D Forrest, I Bence‐Bruckler, ... British Journal of Haematology 203 (5), 781-791, 2023 | 7 | 2023 |
| BCR–ABL1 transcript doubling time as a predictor for treatment‐free remission failure after imatinib discontinuation in chronic myeloid leukaemia in chronic phase DDH Kim, TS Kim, EG Atenafu, I Novitzky Basso, D Forrest, ... British Journal of Haematology 196 (1), 136-145, 2022 | 7 | 2022 |
Jonas MattssonProfessor of Medicine, University of TorontoDirección de correo verificada de uhn.ca
